Bank of New York Mellon’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,121
Closed -$123K 4252
2024
Q1
$123K Sell
1,121
-27
-2% -$3.32K ﹤0.01% 4013
2023
Q4
$152K Sell
1,148
-20
-2% -$2.65K ﹤0.01% 4021
2023
Q3
$141K Sell
1,168
-32
-3% -$4.46K ﹤0.01% 4041
2023
Q2
$248K Sell
1,200
-8
-0.7% -$1.56K ﹤0.01% 3909
2023
Q1
$220K Hold
1,208
﹤0.01% 3879
2022
Q4
$92.4K Sell
1,208
-10
-0.8% -$822 ﹤0.01% 4131
2022
Q3
$110K Hold
1,218
﹤0.01% 4181
2022
Q2
$120K Sell
1,218
-8
-0.7% -$903 ﹤0.01% 4189
2022
Q1
$189K Buy
+1,226
New +$166K ﹤0.01% 4265
2021
Q4
Sell
-126
Closed -$61K 4659
2021
Q3
$61K Buy
+126
New +$95.6K ﹤0.01% 4403
2021
Q2
Sell
-80
Closed -$118K 4463
2021
Q1
$118K Buy
+80
New +$141K ﹤0.01% 4143
2020
Q4
Sell
-25
Closed -$35K 4253
2020
Q3
$35K Hold
25
﹤0.01% 4055
2020
Q2
$36K Sell
25
-3
-11% -$4.79K ﹤0.01% 4017
2020
Q1
$36K Buy
28
+3
+12% +$14.4K ﹤0.01% 4009
2019
Q4
$166K Buy
+25
New +$123K ﹤0.01% 3954

Other funds holding SONM

Bank of New York Mellon's SONM Position: Q2 2024 in Review

Bank of New York Mellon sold out of DNA X Inc (SONM) in Q2 2024, closing a stake of 1,121 shares — an estimated $123K sold.

Bank of New York Mellon first reported a position in SONM in Q4 2019 and held it in 15 quarters. The position peaked at $248K in Q2 2023. 15 funds tracked by Wall St. Rank hold SONM as of Q2 2024.

  • Bank of New York Mellon reported no remaining DNA X Inc position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 1,121 DNA X Inc shares in Q2 2024, an estimated $123K.
  • Bank of New York Mellon first reported a position in DNA X Inc in Q4 2019 and held it in 15 quarters.
  • Bank of New York Mellon's DNA X Inc position peaked at $248K in Q2 2023.
  • 15 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.